Three-dimensional (3D) cell culture models are becoming increasingly popular in contemporary cancer research and drug resistance studies. Recently, scientists have begun incorporating cancer stem cells (CSCs) into 3D models and modifying culture components in order to mimic in vivo conditions better. Currently, the global cell culture market is primarily focused on either 3D cancer cell cultures or stem cell cultures, with less focus on CSCs. This is evident in the low product availability officially indicated for 3D CSC model research. This review discusses the currently available commercial products for CSC 3D culture model research. Additionally, we discuss different culture media and components that result in higher levels of stem cell subpopulations while better recreating the tumor microenvironment. In summary, although progress has been made applying 3D technology to CSC research, this technology could be further utilized and a greater number of 3D kits dedicated specifically to CSCs should be implemented.
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I. INTRODUCTION
Three-dimensional (3D) assays are known to stimulate in vivo cellular conditions better in comparison with traditional two-dimensional (2D) cell culture systems and influence the formation of a subpopulation of cancer cells with stem cell-like properties, providing new insights into cancer treatment and cancer stem cell (CSC) research (Chen et al., 2012) . Recent studies have identified the presence of a small subpopulation of cells within a tumor containing 'stem cell-like' properties. CSCs share some cellular characteristics with non-malignant stem cells, however, they also possess unique physiological attributes. Non-malignant stem cells are vital during development and are present in all tissues with high regenerative abilities; stem cells are able to self-renew and are responsible for sustaining tissue homeostasis and tissue repair following injury (Trumpp & Wiestler, 2008; Rojas-Ríos & González-Reyes, 2014 ). CSCs, originally described in leukemia research, represent a rare subpopulation of cancer cells with unlimited self-renewal capacity and the ability to initiate and sustain tumor growth Rojas-Ríos & González-Reyes, 2014) . Recent studies on cancer research demonstrate that CSCs strongly influence tumor growth and the development of resistance to conventional radiotherapies and chemotherapies. A better understanding of the physiology of CSCs may explain different patient responses to antineoplastic therapies, as well as providing improved insight into the life cycle of tumor cells. CSCs typically possess efficient DNA repair mechanisms, overexpression of anti-apoptotic proteins, expression of multidrug-resistance-type ATP-binding cassette (ABC) membrane transporters, and resistance to hypoxic environments. These attributes may explain the resistance of CSCs to conventional anti-tumor therapies. CSCs, also described as tumor-initiating cells (TICs), differ significantly from non-malignant stem cells. Although the terms CSC and TIC are used interchangeably within the literature, it should be noted that TICs are preferably described as cells containing oncogenic mutations prior to developing into CSCs during tumorigenesis (Gao, 2008) . Additional important CSC characteristics include low proliferation rates, high self-renewal rates, a tendency to differentiate into actively proliferating cancer cells, and possessing natural resistance to current anti-cancer therapies (Neuzil et al., 2007) . Given their 'stem cell-like' properties, CSCs are able to undergo asymmetric division and differentiation into different cell lineages. Furthermore, CSCs are categorized as a side population (a subpopulation of cells distinct from the main population in terms of specific markers) due to their ability to efflux fluorescent DNA-staining dyes via ABC transporters . The concept of CSCs was first postulated when evaluating tumorigenesis in immunodeficient mouse models , and the current concept of CSCs is summarized in Fig. 1 . The recent discovery of experimentally defined CSC precursors from murine lymphoma models, called precancerous stem cells (pCSCs), demonstrates a further tumor cell subset. Depending on microenvironmental signals, pCSCs possess the potential for both benign and malignant differentiation .
Herein we highlight recent advances in the application of 3D assays in cancer research. CSCs cultured using 3D assays can better mimic tumor growth in vitro, as they are more able to overexpress pro-angiogenic growth factors and 'stemness' genes (Smith et al., 2011; Chen et al., 2012) . Further utilization of 3D assay models in CSC research may uncover a range of novel anti-neoplastic therapies. It was recently demonstrated that 3D CSC models show a more realistic drug response, thus allowing for improved drug-resistance studies. This review summarizes 3D cell cultures, along with natural and synthetic scaffolds available in cancer research as well as their roles in understanding the concept of CSCs. Currently available, ready-to use 3D systems, as well as the media components most suitable for 3D culturing of CSCs are discussed. Additionally, the global stem cell market is summarized. Future studies targeting unique CSC molecular characteristics utilizing available 3D assays may provide new oncological treatment targets and therapy modalities. 
II. CANCER STEM CELLS (1) Cancer stem cell model
In recent years, several models of cancer development have been proposed, including the stochastic, hierarchical, and clonal evolution (CSC hypothesis) models (Fig. 2 ) (Gao, 2008) . The stochastic model, now only of historical significance, proposes that all cancer cells within a tumor are homogenous but can reproduce to give phenotypically heterogeneous cell types. The stochastic model does not explain the observed heterogeneity of cancer cells. The hierarchical model, by contrast, proposes that a small subpopulation of cancer cells has the capacity to generate phenotypically heterogeneous cell lines, while other cells within the tumor population possess partial proliferative ability. According to the hierarchical model, a subset of CSCs can only be maintained by cells possessing CSC potential, with their progeny containing partial proliferative ability (Nguyen et al., 2012) . The hierarchical model gives rise to novel cancer treatment concepts, suggesting that elimination of all CSCs may inhibit tumor growth and relapse. The clonal evolution model, consistent with the CSC hypothesis, proposes that malignant cells can mutate and generate abnormal progeny which also have the potential to transform, potentially becoming a dominant cell-line population, leading to the formation of a group of genetically transformed clones all possessing proliferative abilities (Takebe & Ivy, 2010) . According to recent studies, the most accurate cancer model is likely a combination of both the hierarchical and clonal evolution models (Ricci-Vitiani et al., 2007; Takebe & Ivy, 2010) . The revised CSC hypothesis model, incorporating both paradigms, proposes the existence of primary CSCs, which after acquiring a subset of mutations are transformed into a population of secondary CSCs, and then become Fig. 2 . Schematic model of the current cancer stem cell (CSC) hypothesis combining hierarchical and clonal evolution models. This model shows a subset of CSCs which are able to proliferate. These cells have self-renewal properties and are capable of recapitulating a tumor hierarchy. pCSC, precancerous stem cell. Oncogenic mutations are marked by lightning arrows. metastatic CSCs after acquiring further mutations with the potential to form tumors at distant sites. This revised model suggests that a tumor mass contains only a small fraction of metastatic CSCs. The CSC combined model is supported by studies on the hierarchical model of human acute myeloid leukemia (AML), demonstrating that leukemia originates from a primitive hematopoietic stem cell with the potential to differentiate into different cell lines (Bonnet & Dick, 1997) .
The first CSC theories date back to the 19th century. In 1855, Rudolph Virchow postulated a theory of 'embryonal rest', assuming an embryonic origin for tumor cells (Moltzahn et al., 2008) . In 1937, Furth and Kahn proposed the existence of tumor stem cells when studying a leukemia mouse model (Moltzahn et al., 2008) . A recent version of the CSC hypothesis, postulated by Pierce & Speers (1988) , characterized carcinomas as 'caricatures of tissue renewal', being a mixture of malignant stem cells with the ability to proliferate and differentiate under normal homeostatic conditions (Bonnet & Dick, 1997) . In support of the CSC hypothesis, Bonnet & Dick (1997) transplanted single AML cells into mice with severe combined immunodeficiency disease and observed subsequent development of AML in the recipient. The leukemia-initiating cells were able to proliferate, differentiate, and self-renew (Bonnet & Dick, 1997 (Bisignani et al., 1999; Chang et al., 2013) . The majority of CSC studies evaluated cell surface marker expression, including CD34 and CD38 (leukemia), CD44 and CD24 (breast cancer), CD105 (renal cancer), CD133 (colon and brain cancer), and CD271 (melanoma) (Clevers, 2011) . Interestingly, cell surface antigen CD133, although initially considered a marker of malignant stem cells, was later identified in stem cells within normal tissues (Dean, Fojo & Bates, 2005) .
(2) Cancer stem cells and carcinogenesis
CSCs are increasingly recognized as having important roles in tumorigenesis, relapse and metastasis . The earliest documented theory of metastasis was proposed in 1889 by Stephen Paget (Lin et al., 2008) . He proposed that metastasis is dependent on communication between selected cancer cells ('seeds') and specific organ microenvironments ('soil'). His work thus was described as the 'Seed and Soil' theory. The link between the 'seeds' -CSCs/TICs -and metastasis lies primarily within the process of selecting for stress-resistant phenotypes which is externally influenced by specific paracrine microenvironments ('soil'). This hypothesis was revisited subsequently, incorporating proposed stem cell subpopulations consisting of CSCs, mesenchymal stem cells, and circulating endothelial progenitors working in a coordinated multicellular complex (Lin et al., 2008) .
CSCs share many molecular properties with stem cells originally responsible for organogenesis and tissue regeneration (Moltzahn et al., 2008) . Growing evidence has shown that CSCs overexpress traditional stem cell genes, including octamer-binding transcription factor 4 (OCT4), notch homolog 1 (NOTCH1), aldehyde dehydrogenase 1 (ALDH1), fibroblast growth factor receptor 1 (FGFR1), and sex-determining region Y-box 1 (SOX1) (Takebe & Ivy, 2010) . A major difference between normal stem cells and CSCs is the stem cells' dependence on the cellular microenvironment (niche) and growth factors that maintain stem cells by influencing their number, proliferation and fate (Li & Neaves, 2006) . Stem cell niches primarily involve inhibitory signal pathways for both proliferation and differentiation, preventing uncontrolled cellular division and tumorigenesis. CSCs have the potential to influence their cellular microenvironment directly, facilitating local invasion and metastasis.
CSCs possess unique features uncharacteristic of normal stem cells, including hyper-efficient DNA repair mechanisms, over-expression of anti-apoptotic proteins, expression of multidrug-resistance ABC membrane transporters, and resistance to a hypoxic niche (Monzani et al., 2007; Trumpp & Wiestler, 2008) . These characteristics may provide cancer cells with resistance to conventional anti-neoplastic therapies, including chemotherapy and radiation. Efficient DNA repair mechanisms in malignant cells were shown in a human glioblastoma study (Bao et al., 2006) demonstrating that CD133-expressing glioma stem cells repaired radiation-induced DNA damage more effectively than tumor cells lacking CD133. Additionally, the researchers investigated the activities of Chk1 and Chk2 checkpoint kinases; kinase inhibition resulted in increased radiation susceptibility. CSCs affect apoptotic-signalling pathways, primarily through overexpression of anti-apoptotic B-cell lymphoma 2 (Bcl-2) family proteins. Bcl-2 proteins belong to a large family of proteins, consisting of both anti-apoptotic proteins [Bcl-2, Bcl-XL, and induced myeloid leukemia cell differentiation protein (Mcl-1)] and pro-apoptotic molecules [BCL2-associated x protein (Bax), BCL2-antagonist/killer (Bak), BH3 interacting domain death agonist (Bid), BCL2-Like 11 (Bim) -an apoptosis facilitator, BCL2-interacting killer (Bik) -apoptosis-inducing, phorbol-12-myristate-13-acetate-induced protein (Noxa), and P53 up-regulated modulator of apoptosis (Puma)] (Kelly et al., 2007) . In addition to Bcl-2 proteins, CSCs overexpress survivin, a protein belonging to another class of anti-apoptotic proteins, called Inhibitors of Apoptosis Proteins. This family of proteins influences pathways involving cellular division, apoptosis, and pluripotency (Carter et al., 2012) . Inhibitors of Apoptosis Proteins are highly expressed in various CSCs, including glioblastoma (Jin et al., 2008) , hematopoietic (Leung et al., 2007) , and CD34 + /CD38 − AML stem cells (Carter et al., 2012) . Elevated expression of multi-drug resistance genes, belonging to a family of human ABC-transporters, was reported for ABCG2 (encoding P-glycoprotein) and ABCB1 (encoding breast cancer resistance protein 1, BCRP1) in a range of stem cell-like subpopulations (Dean et al., 2005 utilize active transport via ATP hydrolysis to discharge drug molecules from the cellular interior, thus protecting CSCs from chemotherapeutic agents. Another unique feature of CSCs is their adaptation to a hypoxic microenvironment. Glioma cells are able to utilize a hypoxic microenvironment through self-renewal of glioma stem cells mediated by hypoxia-inducible factor 2α (HIF2α), enhancing a stem-like phenotype in the non-stem cell glioma population (Li et al., 2009) . Future studies targeting these unique CSC molecular mechanisms may provide new treatment targets and modalities, leading to the development of novel anti-neoplastic therapeutic agents .
III. GOLD-STANDARD METHODS IN CHARACTERIZING CANCER STEM CELLS
Adult stem cell lineage tracing is a commonly used method perceived as a gold standard in understanding tumorigenic processes (Fink, Andersson-Rolf & Koo, 2015) . One of the initially implemented methods concerned stem cell identification of leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5)-expressing cells in the small intestine and colon. This strategy, combined with the ROSA26-LacZ reporter, allowed the discovery that the Lgr5 + crypt base columnar (CBC) cell population is maintained for a specific period of time and further gives rise to all lineages present in the intestinal epithelium. This identified the Lgr5 + population as intestinal stem cells (Van Der Flier et al., 2007) .
Currently, the mouse is an attractive model in which to study adult mammalian stem cells via in vivo lineage tracing. Numerous genetic fate mapping experiments have been performed in mice with implications for adult stem cell biology (Snippert & Clevers, 2011) .
Adult stem cells are functionally defined by both self-renewal and multipotency, and investigating those criteria is crucial. Surface markers allow preliminary assessments of whether the subpopulation may be of (cancer) stem cell origin or not. On the other hand, genetic lineage-tracing approaches allow in vivo visualization of stem cells in action. It is likely that a combination of both techniques (surface markers and lineage tracing) will be necessary to obtain a complete picture of adult cancer stem-cell biology.
IV. THREE-DIMENSIONAL CELL CULTURE MODELS AND CANCER STEM CELLS
Monolayers, typically formed on polystyrene culture plates, do not allow the establishment of proper cellular microenvironments due to unnatural growing conditions. By contrast, 3D cell culture models enable cells of interest to grow in all three dimensions and form a complex system of information exchange, mimicking the interactions observed in tissue. Such cellular communication occurs between non-malignant, tissue-specific stromal cells, as well as epithelial cells, and also via specific junctions directly between cells and the extracellular matrix (ECM). Since the ECM consists primarily of elastin, proteoglycans, glycoproteins and collagen, this layer is difficult to recreate properly in a basic monolayer culture given the dimensional constraints. Such compounds may be better incorporated in 3D models to mimic the true ECM microenvironment (Kosovsky, 2012) .
Although malignant cells grow relatively well under monolayer conditions -primarily due to their acquired resistance mutations and abnormal metabolic pathways -researchers often encounter difficulties in culturing more delicate differentiated cells, as well as non-malignant stem cells in 2D cultures.
As CSCs are crucial for tumorigenesis, tumor growth, metastasis, and recurrence, there is a need to establish a 3D culture model similar to the conditions of in vivo tumorigenesis. Regarding metastasis and drug resistance, 3D culture models should better facilitate the growth of TICs to mimic actual tumorigenic processes fully. Creating such favourable conditions will result in the presence of molecular events related to metastasis. For example, epithelial-mesenchymal transition (EMT) can be visualized in both 2D and 3D culture models, however, unlike 2D models in which cellular morphology is constrained in a 'flat' plain, 3D models allow the presence of cells corresponding to the metastatic CSCs in vivo, residing at the edge of tumor masses as well as creating spheres, colonies, and aggregates (Marotta & Polyak, 2009; Oskarsson, Batlle & Massagué, 2014) .
Not only do CSCs mimic recurrence conditions better in 3D models, they also show more realistic drug responses. It was demonstrated that growing cells as 3D spheroids can increase resistance to various cancer therapies when compared to the same cell cultures in monolayer (Kimlin, Casagrande & Virador, 2013) . One potential explanation is that cells within the interior of the spheroid colony are protected from drug penetration by neighbouring cells on the periphery of the 3D aggregate. Therefore, regarding cancer drug resistance research, CSCs grown in 3D model assays offer tremendous potential in understanding therapy response rates. Such cells have already been successfully isolated from the 3D model of human osteosarcoma treated by epirubicin. In this manner, 3D CSC models have already provided new insights into tumor drug resistance (Kimlin et al., 2013) .
3D CSC culture models also have the potential to allow better evaluation of cellular proliferation rates and cellular morphology. TICs isolated from different in vivo tumor types exhibited common features: relative quiescent state, self-renewal capacity and a mutual tumor-stem-cell morphological characteristic -their preference to grow in spheroid-like structures. On the contrary, cells growing in monolayers are of flattened shape which induces proliferation at a relatively uniform rate across the polystyrene bottom surface. Growing TICs in 3D induces differential proliferation -cells divide more rapidly at the periphery of the spheroid rather than on the inside due to the lack of cellular adherence molecules. This in turn is caused by the loss of CSC polarity during the EMT process (Feder-Mengus et al., 2008) . Furthermore, the percentage of stem cell markers is often higher in 3D models (Chang et al., 2013) .
3D cancer stem cell models, compared to 2D models, mimic tumor microenvironments better, facilitate the formation of ECM, demonstrate a more realistic drug response, exhibit more adequate proliferation rates with more representative cellular morphology, and stimulate increased expression of 'stemness-related' genes.
(1) Starting material: cells lines or primary tissue
Although using cells isolated from the primary tissue yields results which recapitulate in vivo conditions better, stabilization of a cell line may be problematic and time-consuming. Cell lines obtained from primary cancer tissue have to be 'stabilized' or 'stable'; otherwise it would hinder the study of drug resistance, which requires at least several months of cell culture. In this case, 'stable' does not mean stably transfected with a foreign piece of DNA; it means that the cells are able to divide and survive at least several passages instead of entering plateau phase after 1-3 passages. Such cell lines may be easily shipped around the world, either in a proliferating or a frozen state. They can be also subjected to high drug concentrations for research purposes (Strachan & Read, 2004) . However, only in a small percentage of attempts, depending on the source material, is it possible to obtain a stable cell line from tissue (Bielecka, 2013; Hasmim et al., 2015) . Using stable, widely used and well-known cell lines of specific origin allows longer study periods as well as comparison to the results of other research groups investigating similar topics.
There are, however, two major drawbacks concerning using the use of stabilized cell lines, not only in 3D CSC research, but in stem cell research and in in vitro research in general: (i) the subpopulation of stem cells in stable cell lines is probably significantly smaller than in material newly obtained from a patient; (ii) all currently available cell lines were stabilized in the 1970s -therefore, they might have undergone molecular changes of unknown nature resulting in different genetic, protein and metabolic profiles. Taking these factors into consideration, one must be very cautious about interpreting results yielded with the use of stable cell lines; this approach may be a method of choice when acquiring preliminary data. Yet, any results should be confirmed on a stabilized cell line that is freshly obtained from a patient's cancer tissue.
V. MODIFYING THREE-DIMENSIONAL CANCER STEM CELL MODELS
There are two main techniques when culturing 3D tumorspheres: (i) suspension in serum-free media; and (ii) creating a basement membrane scaffold. Both approaches Chosen commercially available products which may be used for: 3D cancer cell culture (blue circle), stem cell culture (green circle), 3D stem cell culture (light orange bottom circle), or a combination of these. Only those products included in the space with black shading are the group applicable for use in 3D cancer stem cell research. See text for further details of these products. bFGF, basic fibroblast growth factor; ECM, extracellular matrix; EGF, epidermal growth factor; HA, hyaluronan; HGF, human growth factor; OGF, opioid growth factor; PLGA, poly(lactic-co-glycolic acid); TGF-beta1, transforming growth factor beta 1; VEGF, vascular endothelial growth factor. allow for biochemical communication between TICs and the ECM; this interaction is crucial for recreating the tumor-tissue microenvironment observed in vivo (Medema & Vermeulen, 2011) . Either technique allows for modification of CSC niche components by utilizing different reagents, allowing researchers to study CSC-ECM interactions better (Hirschhaeuser et al., 2010) . Individualized 3D cultures can be developed by modifying culture media, growth factors and ECM component additives, or by utilizing specific plates and cellular scaffolds acting as natural or synthetic matrices. Additionally, utilizing different pre-engineered systems can be helpful in creating not only spheres or aggregates, but also colonies. CSCs, when cultured in vitro, grow preferentially as spheroid-like structures. These observed growth patterns are likely related to loss of cellular adherence, resulting from a lack of CSC polarity during EMT (Feder-Mengus et al., 2008; Marotta & Polyak, 2009; Hirschhaeuser et al., 2010) . Figure 3 provides a summarized graphical depiction of commercial products dedicated to 3D cancer models, stem cell cultures, and 3D CSC models.
This section discusses the most useful materials available with which to create a 3D model of greatest similarity to in vivo conditions, i.e. the different culture media, growth factors, hormones, sera, and matrix components. It also presents several additional possibilities, i.e. co-culturing the cells in the presence of stromal components, culture vessels and, finally, natural and artificial scaffolds which may be used in 3D CSC research.
(1) Proposed culture media Currently, only a few types of media specifically designed for stem cell research are commercially available and are utilized for 3D CSC culture models. STEMCELL™ Technologies offer MammoCult™, which is one of the most widely used mammosphere and tumorsphere culture media. This medium is used by breast cancer researchers to study breast CSCs and has been cited in over 60 publications. MammoCult™ has been used to culture over 20 human breast cancer cell lines. Defined and serum-free, it appears to be a successful tool in breast CSC 3D models. Unfortunately the medium is restricted to only one type of cancer (breast), although some attempts have been made with ovarian, lung, and colon tissue Wu, Wang & Zhang, 2013) .
To obtain tumorspheres, which theoretically contain CSCs, serum-free medium is generally used to minimize stem cell differentiation. The typical protocol involves suspending cells in serum-free DMEM/F12 medium containing additives -including bovine serum albumin, insulin, glucose, heparin, basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) -and then seeding in a non-adherent cell culture (Bussolati et al., 2005; Pisanu et al., 2014) . Several companies offer tumorsphere formation media. ProMab Biotechnologies offers Cancer Stem Medium Premium™ for tumorsphere formation in breast, ovarian and hepatocellular cancer studies. Irvine Scientific offers PRIME-XV Tumorsphere SFM Medium™ combined with supplements, such as heparin and hydrocortisone, to be used in a variety of human tumor research, including breast adenocarcinoma, cervical carcinoma and alveolar adenocarcinoma. R&D Systems offer a semi-solid StemXVivo Serum-Free Tumorsphere Medium, dedicated to human, mouse, and rat cancer cell lines. Celprogen manufactures a wide variety of both complete media (with serum and antibiotics) for CSCs, as well as serum-free media designed separately for the following malignancies: liver, colon, gallbladder, lung, head and neck, stomach, melanoma, kidney, osteosarcoma, ovarian, leukemia, oesophagus, pancreatic, brain, breast, neuroblastoma, glioma, prostate, and papillary thyroid cancers. Each cell culture requires a special flask, pre-coated with ECM. Several stem cell markers are claimed to be preserved until the 12th passage, including CD44, CD133, SSEA 3/4, OCT4, SOX2, Nanog, c-Kit, Nestin, and Lin28 (Sharma et al., ) .
A wide range of media products exist for culturing stem cells, however, none of these companies endorse their media for use in 3D cancer stem cell models except for tumorsphere formation. Nonetheless, it is likely that all these media can be utilized for the propagation of CSCs in 3D models.
(2) Proposed growth factors
Media supplementation with growth factors in 3D CSC cultures is used to induce 'stemness' features, increase tumorigenicity in xenotransplants, and to induce tumorsphere formation (Malaguarnera & Belfiore, 2014) . Media supplementation, such as adding growth factors, has been shown previously to induce 'stemness' features in non-tumorigenic human mammary embryonic cells (Malaguarnera & Belfiore, 2014) . In order to induce sphere formation in 3D cancer stem-like cell assays, serum-free medium, such as DMEM, is usually supplemented with bFGF/human recombinant bFGF (hrbFGF) and EGF/human recombinant EGF (hrEGF) (Schroeder et al., 2014) . When studying human mammary embryonic cells, bFGF/hrbFGF was added at a concentration of 20 ng/ml and EGF/hrEGF at 10 ng/ml. Luo et al. (2006) demonstrated that bFGF effectively increases cell proliferation. Under such conditions, combined with the addition of insulin, cancer cells are able to grow as suspended spheres. In order to evaluate cellular differentiation, clones can be incubated in differentiating media (such as EBM medium from Cambrex Bio-Science) supplemented with vascular endothelial growth factor (VEGF) (manufactured by Sigma-Aldrich). VEGF is known to act as a major inducer of angiogenesis in tumors, interacting with bFGF and EGF (Danielsen & Rofstad, 1998) . Interestingly, studies on human renal cancer demonstrated a role for opioid growth factor (OGF) which inhibited renal cancer cell proliferation in tissue culture; OGF may play a role in future novel treatment therapies for renal cancers (Bisignani et al., 1999) . Growth factors play important supporting roles in 3D culturing and tissue engineering. For example, transforming growth factor-β1 (TGF-β1) (4 ng/ml; Sigma-Aldrich) was shown to induce matrix contraction and enhanced collagen and sulfated glycosaminoglycan production, while hepatocyte growth factor (HGF) (20 ng/ml; Chemicon) stimulated synthesis of hyaluronan (HA) and elastin (Luo et al., 2006) .
(3) Emerging role of hormones in CSCs and 3D CSC models
A growing body of evidence highlights the importance of ovarian steroid hormones (progesterone and oestrogen) and androgens in the regulation of CSC populations. Ovarian steroid hormones are involved in the development and homeostasis of the mammary gland by regulating proliferation, differentiation, and apoptosis (Vares et al., 2013) . These hormones can influence mammary stem cell numbers and breast adenocarcinoma progression (Joshi et al., 2010) .
Progesterone was recently shown to stimulate expansion of breast CSCs (Vares et al., 2013) . Additionally, progesterone has been shown to influence stem cell regulatory pathways, including Notch and interleukin (IL-6 and IL-8) pathways (Axlund & Sartorius, 2011) . Moreover, there is a strong body of evidence demonstrating that oestrogen can stimulate breast CSC expansion through paracrine FGF/Tbx3 signalling (Fillmore et al., 2010) . Additionally, steroid hormones were shown to initiate the process of EMT, a process where adherent epithelial cells lose their epithelial characteristics and acquire mesenchymal properties, resulting in the generation of malignant cells with properties of stem cells (Malaguarnera & Belfiore, 2014) . To study the impact of ovarian steroid hormones on CSC populations, natural progesterone and oestrogen diluted in ethanol (10 mM) can be added to culture media, as described by Vares et al. (2013) .
Androgens, which are involved in prostate gland development, play key roles in prostate cancer initiation and progression (Schroeder et al., 2014) . Seiler et al. (2013) demonstrated that androgen deprivation may contribute to functional enrichment of putative prostate CSCs. Experiments can be performed under androgen-dependent (regular medium) or androgen-depleted (medium containing charcoal-stripped serum) conditions. Androgen deprivation and androgen receptor target-based therapies are associated with selecting for tumor cell resistance; it was observed that downregulation of androgen receptors contributes to the development of prostate cancer CSCs. Cells in these experiments were cultured in DMEM medium supplemented with 10 nmol/l of dehydroisoandrosterone (Sigma-Aldrich).
Insulin and insulin-growth factor signalling pathways are also known to play crucial roles in the maintenance of a stem-like phenotype of cancer cells by contributing to EMT regulation, pluripotency, and self-renewal (Malaguarnera & Belfiore, 2014) . Insulin is usually added to serum-free DMEM media with growth factors as described by Schroeder et al. (2014) .
(4) Presence or absence of serum in (3D) CSC models
Recent studies demonstrated that CSC clonal expansion requires media lacking animal-derived serum (Brunner et al., 2010; Zhou et al., 2010; Tekkatte et al., 2011) . Serum is believed to stimulate cellular differentiation. Recently, due to ethical issues, animal components, including animal sera, are slowly beginning to be removed from laboratory use. The '3R' rule (reduce, refine and replace) aims at eliminating foetal or newborn bovine and calf sera from research practice (Balls et al., 1995) .
To recreate fully the best conditions for CSC growth in 3D media while inhibiting cellular differentiation, certain parameters controlling cell proliferation need to be manipulated. Important cellular parameters include cell-cell interactions, soluble factors, cell-matrix interactions, cell architecture, polarity, and cell-ECM interactions. Since animal serum contains large quantities of different biomolecules, adding each component separately to media is challenging (Brunner et al., 2010) . Human-derived medium additives, which may substitute for fetal bovine serum (FBS), the most popular serum in basic research, have been under investigation for many years; human serum is both autologous and allogenic. Some examples of alternative components to animal-derived sera include human serum albumin, thrombin-activated platelet releasates, collagen-activated platelet releasates, human platelet lysates, and umbilical cord blood serum. These alternatives, although reducing the risk of secondary effects caused by FBS in cell cultures, such as cellular differentiation, are currently not widely used in CSC cultures (Tekkatte et al., 2011) .
(5) Extracellular matrix components and their impact on the relevance of 3D CSC models
Several attempts have been made to culture CSCs with specific ECM components to best mimic in vivo conditions (Tekkatte et al., 2011) . The ECM is initially tightly regulated during embryogenesis and organ homeostasis and becomes increasingly deregulated and disorganized during carcinogenesis.
ECM is known to be an essential, dynamically changing component of a cell's surroundings and is biochemically different when comparing malignant and non-malignant cells. The ECM can be subcategorized into basement membrane and interstitial ECM. The basement membrane has a distinctive composition consisting of type IV collagen, laminin, fibronectin, nidogen, and enactin. The interstitial matrix is mostly built from fibrillar collagens, proteoglycans, and various glycoproteins including tenascin C and fibronectin. As a result, the ECM is highly charged and hydrated, contributing to a tissue's specific elastic properties (Egeblad, Rasch & Weaver, 2010) .
In tumors, however, the ECM becomes stiffer. Additionally, its biomechanical and physical properties change; interestingly, ECM dynamic studies may show either no effect in compositional change or minimal changes in molecular cross-linking or spatial arrangement (Lu, Weaver & Werb, 2012) . Tumor ECM may still be composed primarily of matrix proteins, including collagens, fibronectin, glycoproteins, proteoglycans, and laminins. However, increased deposition of collagen I, II, III, V, and IX was observed during tumorigenesis with overproduction of heparan sulfate proteoglycans and cellular marker CD44 (Kainz et al., 1995) .
ECM also plays important roles within a CSC's niche. Ligand receptors within the ECM allow stem cells to attach to the special local microenvironment (Lu et al., 2012) . Moreover, the ECM likely influences the developmental fate of cancer stem cells via the integrin signalling pathway. Integrins were shown to interact actively with ECM proteins. Such interactions result in the activation of signal transduction pathways which control critical steps during carcinogenesis -migration, gene expression, polarity, survival, differentiation, and proliferation (Van Der Sanden et al., 2010) .
In 3D CSC studies evaluating tumor drug resistance, it is possible to mimic in vivo tumor ECM. The dense ECM may function as a physiological barrier, preventing targeted therapies from reaching clinically relevant dose concentrations. Additionally, natural collagens, which are the primary ECM components, often accumulate in response to drug administration when studied as a cellular scaffold, has been shown to maintain stem cell self-renewal and pluripotency (Hughes, Postovit & Lajoie, 2010) . Both naturally derived and synthetic scaffolds are discussed below (see Sections 8.10 and 8.11).
(6) Comparison of in vitro culture conditions to the known in vivo CSC niche
The CSC niche is characterized as a tumor-specialized microenvironment promoting the appearance of tumor stem cells while providing at the same time all the factors required during their development process. Interestingly, CSCs are known to present a quiescent state in vivo whereas they exhibit greater proliferative activities than non-CSCs in vitro (Gibbs et al., 2005; Iwasaki & Suda, 2009 ). Moreover, activation of hypoxia signalling pathways, including HIF-1 and HIF-2, enhances CSC maintenance (Heddleston et al., 2010) .
The most important component of the CSC niche is the ECM; this is crucial for obtaining the specific CSC phenotype. Adaptation of in vitro cell culture protocols to this requirement was recently shown to allow CSC-niche interactions to be maintained. The most reliable model seems to be a 3D assay based on Matrigel rich in ECM (Alvero et al., 2009 ) which maintained the growth of heterogeneous hierarchical CSC cultures. Incorporation of the ECM component, laminin, in serum-free media increased tumor cell growth, self-renewal and tumorigenic features in glioma CSCs (Pollard et al., 2009) .
Selecting an appropriate set of proteins characteristic of the ECM and optimal for CSC culture conditions is likely to have a positive effect on the development of an appropriate in vitro environment for investigations into CSCs.
(7) Hypoxia or normoxia/physioxia in 3D CSC models -seeking the optimal solution
Oxygen concentrations in the human body may be hypoxic (0.1-1% O 2 ), physioxic or physoxic (∼1-13% O 2 ), and normoxic (∼20% O 2 ). Hypoxic conditions [inter alia those resulting from altered HIF pathways, i.e. the hypoxia-inducible factor (HIF)-von Hippel-Lindau (VHL) pathway in clear-cell renal cell carcinoma] are a typical feature of most tumors (Keith & Simon, 2007; Schödel et al., 2015) . Given that hypoxia plays a crucial role in tumor progression and resistance to therapy, this might be the best-validated target to date in molecular oncology (Wilson & Hay, 2011) and also may be significant in the context of cancer stem cells. Recently it was reported that hypoxia promotes CSCs via inhibitor of DNA binding 2 (ID2)-dependent VHL inactivation (Lee et al., 2016) . Furthermore, 3D conditions creating a specific niche together with hypoxia act synergistically to maintain the CSC phenotype (Collet et al., 2015) , in this case a CD133 + subpopulation of osteosarcoma cells (Gorgun et al., 2015) . The best approach may be to culture cells in 3D CSC models in hypoxic conditions, while also maintaining parallel controls in normoxia and/or physioxia.
(8) Co-cultures in 3D models: seeding cells in the presence of stromal components
The impact of stromal cell components on the tumor microenvironment was described in several studies (Bezdenezhnykh et al., 2014; Wan et al., 2014; Zhang, Cai & Li, 2015) . It is known that since the molecular composition of the microenvironment of the tumor is formed not only by cancer cells and CSCs and their metabolic products, but also by resident/infiltrating non-tumor cells, inter-and intracellular interactions may be difficult to recapitulate in in vitro conditions. Therefore, some researchers have proposed a co-culture model in 3D CSC research, i.e. long-term microencapsulated 3D co-cultures (Estrada et al., 2016) . This approach might be successful in suspension co-cultures in serum-free media.
(9) Culture vessels and 3D CSC models
Growing CSCs in 3D assays requires conditions that mimic specific tumor microenvironments, enabling cells to grow as 3D aggregates or spheroids. It was previously demonstrated that although it is possible to grow tumor cells in monolayers on polystyrene culture vessels, the cultured tumor cells may lose their stem cell-like properties. Specifically, cell morphology, function and ECM interactions are altered, resulting in reductions in growth factor and stem cell marker expression.
Many companies have proposed interesting solutions involving alterations of culture vessels for growing cancer cells in 3D assays. Thermo Scientific™ offers Nunclon™ Sphera™ Flasks available as T25 and T75 cell culture flasks, which are suitable for optimizing sphere formation and 3D cancer cell growth. These flasks allow cells to grow in suspension with minimized cellular attachments. Corning Inc. offers spinner flasks, which grow tumor spheroids in dynamic suspension, thus preventing adherence by inhibiting cellular contact with the culture vessel walls (Kim, 2005) . Spinner flasks function as stirred tank bioreactors. Standard 96-well tissue culture plates can be used for monitoring individual spheroid growths and for co-cultures isolated from spinner flasks. Ekert et al. (2014) proposed generating tumor spheroids by plating lung tumor cells at 1 × 10 4 cells/well into 'U' bottom Ultra Low Adherence (ULA) 96-well plates (Corning) at 200 μl/well. These plates are known to stimulate spontaneous formation of a single spheroid of cells within 24 h (incubation at 37
• C, 5% CO 2 ). Vinci et al. (2012) described a sphere formation assay using the same ULA 96-well plates (Corning). Spheroids grown on ULA plates showed a more compact structure in comparison with standard agar-coated plates.
One of the most interesting culture vessel systems used in 3D CSC research, designed by 3DBiomatrix, is
Perfecta3D
® Hanging Drop Plates, available in both 96-well and 384-well formats. These plates allow efficient formation of uniform-size spheroids, mimicking tissue metabolic and proliferative gradients, as well as simulating in vivo cell-matrix and cell-cell interactions (Tung et al., 2011) . They are particularly useful in tumor spheroid assays, drug testing, and stem cell differentiation studies.
(10) Natural scaffolds
Until recently, only natural scaffolds were utilized in 3D cell culture. The main benefit of utilizing a natural scaffold is the implementation of natural ECM components, including protein-based and polysaccharide-based biomaterials. Protein-based biomaterials, such as collagen, achieve optimal structural integrity among cells (Barzegari & Saei, 2012) . Enhancement of CSC properties in 3D collagen scaffolds was observed in breast cancer cell lines (Chen et al., 2012) . Another protein, gelatin, a product resulting from controlled collagen hydrolysis, may serve as a good substrate in 3D cell culture models as it has been used successfully as a carrier for anti-neoplastic drug delivery. Elastin, a structural protein found within native ECM, is also used in 3D CSC cultures. It is more flexible than collagen and seems to be a more effective choice. Fibrinogen or fibrin is also added to scaffolds; it enhances cellular and matrix interactions via integrin binding sites (Barzegari & Saei, 2012) . Silk may also be considered for incorporation into cellular scaffolds; it is composed from sericin, a protein holding fibres together, and a fibroin filament component serving as the mechanical backbone. It has been reported that bone marrow stem cells successfully proliferated on silk-based scaffolds (Mano et al., 2007) .
The most commonly used polysaccharide-based biomaterial in 3D colony formation assays is agarose (Willerth & Sakiyama-Elbert, 2008) . Alginate, another utilized polysaccharide, forms scaffolds through the use of ionic cross-linking, allowing for encapsulation of cells, and has been successfully used in a series of cancer treatment studies (Shah, 2013) . However, two additional polymers may be more effective than either agarose or alginate. HA which contains sites for cellular adhesion, was shown to mimic in vivo tumor growth better (Martínez-Ramos & Lebourg, 2014) . It is highly expressed in malignant tumors and is an integral component of the microenvironment of metastatic cancer cells. The second alternative polysaccharide is chitosan, a biopolymer derived from chitin, which exhibits outstanding biocompatibility and biodegradability due to the presence of primary amines along the chitosan backbone. Both of these polysaccharides show high potential for improved culturing of 3D CSC models (Croisier & Jérôme, 2013) .
Natural scaffolds typically contain more than one material, therefore combinations are possible. For example, chitosan-alginate scaffolds are usually prepared by incorporating ionic bonds of the chitosan amine group with the carboxyl group of alginate. Such mixed materials have been shown to exhibit considerably improved mechanical strength when compared to chitosan or alginate scaffolds alone. Combined scaffolds are less immunogenic, while at the same time being more compatible, stable, and biodegradable. Mixed-scaffold compositions have also been shown to mimic stem cell niches better Kievit et al., 2014) . Combined chitosan-HA scaffolds have been developed as well. Although the negative charge of HA hinders cellular adhesion, when combined with chitosan -a cationic polymer -this ionic interaction actively promotes cellular attachment to the 3D porous scaffold (Florczyk et al., 2013) . Natural 3D scaffolds have been shown to enhance CSC properties, as well as improving EMT and stem cell enrichment Martínez-Ramos & Lebourg, 2014) . They also provide sites for cellular adhesion and are biocompatible (Martínez-Ramos & Lebourg, 2014) .
One limitation of using natural scaffolds is a thickened ECM, resulting in inhibition of passive diffusion of nutrients into the cells. Additionally, variability and quality inconsistencies are possible. Due to these potential limitations, careful optimization is needed when applying natural scaffolds to 3D CSC culture research (Willerth & Sakiyama-Elbert, 2008) .
(11) Synthetic scaffolds
Given that natural scaffolds run the risk of contamination, degradation, and have the potential for heterogeneous effects on cellular proliferation, differentiation, and migration, synthetic scaffolds have been developed (Tibbitt & Anseth, 2009) . Synthetic scaffolds are attractive alternatives to natural matrices due to their mostly biodegradable composition, as well as positive biomimetic features like matrix mechanical properties, porosity, and degradation profiles (Hutmacher, 2010) . These pre-engineered, biodegradable, non-cytotoxic synthetic scaffolds are typically composed of porous polymeric microparticles, such as L-lactic acid, poly(lactide-co-glycolide) (PLGA), polycaprolactone (PCL) or hydrogel (Kang & Bae, 2009; Tibbitt & Anseth, 2009; Rao et al., 2014) . It is likely that synthetic scaffolds can be effectively utilized in 3D CSC cultures.
Hydrogels are composed of poly(ethylene glycol) (PEG), poly(vinyl alcohol) or poly(2-hydroxy ethyl methacrylate) (Tibbitt & Anseth, 2009) . PEG hydrogels preserve the viability of cells; however, they are devoid of the endogenous factors which support cell growth, and thus behave mostly as a template to facilitate basic cellular duties (Cushing & Anseth, 2007) .
Porous polymeric scaffolds, like poly-PLGA microspheres, supply a large surface area for cancer cell cultures, enhance physical support of cells, and provide a substrate for expanding cells, areas of attachment, and enhance tissue regeneration (Kim, 2005; Kang & Bae, 2009) . Scaffolds based on porous PLGA were shown to facilitate oxygen and nutrient transport through microspheres, providing adhesion and proliferation of MCF-7 tumor cells, as well as improving viability and functionality even after cryopreservation (Kang & Bae, 2009 Interestingly, synthetic PCL fibrous scaffolds were shown to increase the proportion of cultured CSCs (Feng et al., 2013) . This was based on the observation of overexpression of stem cell markers in MCF-7 cells, including OCT3/4 and SOX2, and breast CSC-specific markers SOX4 and CD49f. Moreover, MCF-7 cells cultured on this scaffold showed enhanced cellular proliferation rates. Furthermore, the investigators observed upregulation of EMT and enhanced invasive abilities of these cells and proposed the use of these scaffolds for anti-cancer drug screening and enrichment of CSCs.
3D CSC culture assays utilizing polymeric scaffolds, both natural and synthetic, have proved to be an attractive biomimicking model system with which to study the effects of tissue microenvironment conditions on malignances (Fischbach et al., 2007; Kang & Bae, 2009) . Additionally, 3D tumor models can be used for in vitro evaluation of anticancer drugs (Horning et al., 2008) . For example, utilization of porous biodegradable polymeric microparticles as a scaffold for 3D culturing of the breast cancer MCF-7 cell line has allowed demonstration of the antiproliferative effects of multiple antineoplastic drugs, including doxorubicin, paclitaxel and tamoxifen (Horning et al., 2008) .
(12) Commercial 'ready-to-use' three-dimensional kits
Most of the kits utilized in cancer research use biomimetic scaffolds based on synthetic hydrogels (3D Biotek, ESI-BIO -HyStem Hydrogels, and QGel), polystyrene (Reinnervate and 3DBiomatrix) or collagen (Glycosan and RAFT™). Manufacturers have not reported direct involvement of these kits in CSC research, however, like scaffold kits, these 'ready-to-use' kits are being utilized with increasing frequency in the field of CSC research. For example, 3D models using scaffolds based on HA have been shown to be similar to tumor growth in vivo and to promote stem cell-like phenotypes through analysis of cell surface marker expression (Martínez-Ramos & Lebourg, 2014) .
3D Biotek offers scaffolds for 3D cultures, useful not only for tissue engineering and drug discovery, but also for CSC research. The company offers three scaffold types: 3D Insert™-PCL and 3D Insert ™-PLGA designed on the basis of biodegradable synthetic scaffolds, and the non-degradable scaffold polystyrene (PS) 3D Insert™-PS, composed of the same material used in traditional tissue culture plates. These scaffolds are pre-sterilized, ready-to-use, offer easy monitoring of cellular growth, are mostly free of animal-derived material, improve cell culture efficiency, minimize absorbance of cytokines and growth factors, and facilitate the separation and recovery of cells from the culture medium. MCF-7 tumor cells cultured on 3D scaffolds from 3D Biotek, as compared with cells cultured in 2D media, had significantly enhanced cellular proliferation and metabolic activity rates. Additionally, 3D Biotek has developed a 3D cell transfection kit, consisting of a sterile plate containing 3D cell culture scaffolds and a 3D transfection reagent (BioCellChallenge, SAS a 3D tissue culture system made of polystyrene, is sterile, and facilitates efficient formation of tumor spheroids of uniform size. This system has the potential to decrease the high incidence of false-positive results in anti-cancer drug screening; it is also useful in CSC research, and therefore, highly recommended.
VI. THREE-DIMENSIONAL CANCER STEM CELL CULTURE SYSTEMS
3D CSC culture systems can be designed and implemented using engineered devices that mimic the tumor microenvironment and maximize cell-cell interactions. Several models are currently being used in 3D CSC research and are summarized below and in Table 1 (Xu, Farach-Carson & Jia, 2014) . Kuo et al. (2014) (1) The multicellular tumor spheroid model
Developed by Sutherland et al. (1970) the multicellular tumor spheroid (MCTS) model consists of either a liquid overlay, hanging drop, or suspension culture. It uses traditional cell culture plates or spinner flasks (Sutherland et al., 1970) . This model facilitates formation of spheres and aggregates of cells, some of which may contain CSCs. In order to introduce physiologically relevant biomechanical, biochemical, or biophysical stimuli to cultured cells, bioreactors seem to be necessary. This model has been used to study the expression profile of stem cell signalling in CD133 high /CD44 high prostate cancer stem cells and glioblastoma tumor-initiating cells (Oktem et al., 2014) . Additionally, this technique has demonstrated that human lung cancer cell line SPC-A1 contains a subpopulation of CSCs (Zhou, Yang & Li, 2012) .
(2) Suspension bioreactors
Large-scale production of human glioblastoma-derived CSCs in the form of specific tissue lines has been proposed by Intech Open. These cells could be created in special suspension bioreactors and would facilitate the development of novel anti-neoplastic therapeutics. Brain CSCs have been isolated and produced on a large scale using a similar method (Panchalingam et al., 2011) . Suspension bioreactors have been used since their development in 2006 to culture breast CSCs on a large scale (Youn et al., 2006) .
(3) Rotating wall vessel technology
Conventional bioreactors have limitations. Generating stem cell and tissue constructs that fully recapitulate in vivo pathophysiology is difficult. As a potential solution, recent studies evaluating microgravity tissue engineering technology have used NASA-developed rotating wall vessel (RWV) technology (Barzegari & Saei, 2012) . This rotary culture system has been used to study morphological differentiation of colon carcinoma cell lines HT-29 and HT-29KM, revealing some embryonic-like mesenchymal cell subpopulations. Prior studies showed successfully that RWV technology may facilitate research into biochemical processes of both neoplastic and normal tissues (Goodwin, Jessup & Wolf, 1992) .
(4) Hydrodynamic focusing bioreactor
Another NASA-developed system, now produced by Celdyne, has been successfully used in the selection of CD133 + osteosarcoma cells. In a comparison in which CD133 + cells were isolated and cultured from osteosarcoma SAOS-2 cells using both hydrodynamic focusing bioreactors and rotating wall vessels there was an almost fivefold greater number of CD133 + cells cultured using hydrodynamic focusing bioreactors. Isolated CSCs were sensitized to chemotherapy agents after being cultured in a hydrodynamic focusing bioreactor (Kelly et al., 2010) .
(5) Biomimetic nano-cilia and microfluidics
A culture model consisting of triblock copolymers (Pluronic F108 'nano-cilia') was proposed initially for spheroid tissue cultures to enhance EMT properties. This technology was subsequently implemented for the modelling of cancer metastasis and drug resistance (Kuo et al., 2014) . Various cancer cell lines of different origins have been cultured using a special device based on a hydrated layer containing 'nano-cilia'. These biomimetic 'nano-cilia' stimulate tumor spheroid formation. With the incorporation of microfluidics, one can control cellular differentiation as well as epigenetic reprogramming of tumor cell subpopulations. This new technology provides a valuable model for the selection of CSCs independent of 'stemness' markers (Kuo et al., 2014) .
VII. RECENT ADVANCES IN THREE-DIMENSIONAL CANCER STEM CELL TECHNOLOGIES
3D stem cell culture systems are becoming increasingly popular and successful in molecular oncology studies. 3D stem cell platforms are now widely used with multiple cancer varieties.
In order to investigate the current model of CSC origin and development (see Section II.1 and Fig. 2 ), a variety of experimental 3D assays are now available. The first system utilizes a non-adherent tumor sphere assay which can help to recognize progenitor cells (Visvader & Lindeman, 2008) . This experimental system depends on the generation of tumor spheres by putative CSCs. During serial passages, a subgroup of CSCs in one sphere can induce formation of new tumor spheres. It is important to note that spheres can develop as a result of aggregation of tumor cells, and to rule this out it is worth checking the clonal nature of an event at a single-cell level. An alternative experimental assay for CSC hypothesis testing as well as progenitor cell potential testing is the tumor-colony forming ability approach. Another useful experimental in vivo assay is the orthotopic transplantation of identified CSCs using immunocompromised recipient mice.
Recent advanced 3D assays have been utilized to study cancer cell lines. In brain cancer stem cells, novel 3D constructs were designed with HA cell carriers (Martínez-Ramos & Lebourg, 2014) . The investigators developed a combination of both synthetic and natural scaffolds which stimulated U87 (astrocytoma) cells to exhibit a stem cell phenotype. To accomplish this, tumor cells were grown on polycaprolactone (PCL-2D) flat substrates and PCL-3D scaffolds with HA. Both scaffolds supported cellular proliferation and migration, as well as cluster formation and overexpression of marker CD133 (Martínez-Ramos & Lebourg, 2014) .
A successful 3D cancer platform model with increased stem cell properties using scaffolds based on a combination of chitosan and HA was created for the analysis of glioblastoma (Florczyk et al., 2013) . Similarly, EMT and CSC phenotypes (Nanog, SOX2, CD44, CD133, N-cadherin, and vimentin-positive cells) have been isolated using chitosan-HA membrane-derived 3D tumor spheroids for non-small cell lung cancer research (Chang et al., 2013) .
Enhancement of CSC properties in culture isolates from the mammary gland has been studied in other commercial 3D systems, such as MCF-7 (breast cancer) cells cultured in 3D scaffolds for modelling cancer progression and assessment of antineoplastic drug resistance. Not only did these studies demonstrate upregulation of EMT markers, but downregulation of epithelial cell markers was also observed. The overexpression of stem cell markers (OCT4A and SOX2) and breast cancer stem cell markers [SOX4, Jagged 1 (JAG1) and CD49F] was reported as well. The cellular platform consisted primarily of collagen.
Interestingly, the Society for Biomaterials recently published a study demonstrating that 3D collagen scaffolds also enhance the percentage of cultured CSCs and EMT properties in another cancer cell line -human adenoid cystic carcinoma cells (ACC-83). Both SOX2 and OCT4 exhibited significantly higher expression in 3D than in 2D cell cultures. It should be noted that cells from the 2D cultures were harvested in medium containing 10% FBS (aiming at cell differentiation), whereas the 3D culture medium contained 50% FBS. Regardless of differences in media composition, quantitative reverse transcription polymerase chain reaction revealed upregulation of EMT and CSC markers in the 3D culture media .
Similarly, several studies on human osteosarcoma cell lines have established enhancement in EMT properties. Serum-free, 3D CSC culturing appears to provide superior results with regard to isolating CSCs with increased EMT characteristics (Zhou et al., 2010) . The primary cells were prepared from a single-cell suspension and were mixed homogeneously into 1.2% alginate gel. Some of the resulting isolated cells were positive for CSC markers, including OCT3/4 and Nanog.
Another major discovery in the field of 3D CSC model research is on the effective enrichment and culturing of CSCs; this is important to the understanding and development of novel methods for the treatment of prostate cancer. Researchers utilized liquid core-hydrogel shell microcapsules to achieve successful enhanced enrichment of prostate cancer stem-like cells. This strategy allowed the isolation of CD44 + and CD133
+ cells after only 2 days of incubation (Rao et al., 2014) .
A significant breakthrough in 3D CSC research was the recent establishment of a human colorectal cancer cell line (CR4) with putative CSC properties (Rowehl et al., 2014) . This highly tumorigenic cell line, originally derived from liver metastasis, was obtained by combining several approaches: 3D and 2D culturing in stem cell media, subcloning of cells characterized with specific features, co-culturing with carcinoma-associated fibroblasts (CAFs) and serial transplantation to NOD/SCID mice. The CR4 cell line possesses 3D spheroid-forming and holoclone-forming capacities; it also expresses both pluripotency and stem cell markers [V-Myc avian myelocytomatosis viral oncogene homolog (c-Myc), SOX2, OCT3/4, CD133, CD44]. Additionally, it has been shown to induce the formation of paraclones with a diffuse-edge phenotype which is typical for progenitor cells.
Designing 3D CSC models is a challenge both for researchers in basic sciences and for clinical applications. Nonetheless, recent technological advances in the field of 3D culture models may improve the progenitor features of cancer cells, as well as enhancing the enrichment of stem cell subpopulations. Results from these advances may subsequently be utilized for in vitro screening of antineoplastic drug resistances (Peyton et al., 2011) . Isolation of cancer cell lines with CSC properties using experimental 3D systems may help to uncover important new tools in the discovery of novel diagnostic and prognostic biomarkers and could contribute to the development of more effective therapeutic strategies.
VIII. CONCLUSIONS
(1) Despite recent advances in 3D CSC culture model research, limitations remain. One of the most significant current limitations is the lack of predictive or prognostic stem cell markers for specific cancers that are widely accepted and approved in CSC research.
(2) We cannot be sure that molecular markers currently classified as stem cell markers truly correspond to CSCs. Until recently, no commercially available biomarker existed that reliably confirmed successful culturing of CSCs in 3D culture models (Mehta et al., 2010) .
(3) Huge scientific progress has been made in the application of 3D culturing technology to CSC research in recent decades. Nevertheless, much remains to be done to further utilize this technology in the development of improved prognostic, predictive, and drug-testing tools in cancer research. 
